TBHC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
TBHC is not a good buy right now for an impatient investor. The trend is still decisively bearish (bearish moving-average stack and worsening MACD), the near-term pattern stats point to downside over the next week, and the latest quarter shows deteriorating revenue, margins, and losses widening. Options positioning looks call-heavy, but implied volatility is extremely elevated, making bullish bets expensive and more consistent with speculative sentiment than a high-confidence bottom.
Price/Trend: Bearish. Moving averages are stacked bearishly (SMA_200 > SMA_20 > SMA_5), implying a sustained downtrend. Momentum: MACD histogram is negative (-0.0114) and expanding lower, confirming downside momentum is strengthening. RSI: RSI_6 at 31.4 is near oversold territory, which can support a short-term bounce, but it is not enough to override the broader downtrend. Levels: Pivot 1.297 is overhead resistance; additional resistance at 1.412 and 1.483. Key supports are 1.183 then 1.112. With post-market around ~1.22, price is relatively close to S1 (1.183); a break below S1 increases risk of a move toward S2. Pattern-based near-term odds: Similar-pattern projection suggests ~-2.35% over the next week and only modest +0.48% over the next month—skewed against an immediate entry.
RSI near oversold (possible short-term mean reversion bounce if support at ~1.18 holds).
Options open interest is heavily call-leaning (could amplify upside if a catalyst appears).
No recent negative news headlines flagged in the last week (absence of fresh shocks).
Downtrend is intact and momentum is worsening (bearish MA stack + expanding negative MACD).
Latest quarter fundamentals weakened materially (revenue down YoY, margins down, losses deeper), which can cap rebounds.
Very high implied volatility suggests the market expects big swings; for a buyer, this often means paying up for uncertainty.
No identified event-driven catalysts/news in the past week to justify a sudden trend reversal.
No supportive flows signal: hedge funds and insiders are neutral; no notable accumulation trend.
Latest reported quarter: 2026/Q3. Revenue: 103.462M, down -9.58% YoY (top-line contraction). Net Income: -3.705M, down -51.76% YoY (losses worsened). EPS: -0.16, down -72.88% YoY (profitability deterioration). Gross Margin: 19.88%, down -27.31% YoY (margin compression). Overall: Growth and profitability trends are negative, which reduces the odds that a technical bounce turns into a durable uptrend without a clear catalyst.
No analyst rating or price-target change data was provided, so a Wall Street pros/cons consensus trend cannot be confirmed from the dataset. Based on the available fundamentals and trend signals alone, the near-term pro case would be 'oversold bounce potential,' while the con case is 'deteriorating financials and a confirmed bearish trend.'
